EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

NCT05625672 | Completed

• 1 other identifier: 2022-38
• Study Type: interventional
• Target: 125
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.

Conditions

Nurse's Role; Training Group, Sensitivity

Outcome Measures

Primary Outcomes (3)

• Hemovigilance Information Form

  It consists of fifteen questions about hemovigilance and hemovigilance system and definitions.

  5 hours or 1 month

• Information Form on Blood Transfusion Complications

  This section consists of nine questions including transfusion complications.

  5 hours or 1 month

• Information Form on Blood Transfusion Applications

  This section consists of sixteen questions including donor selection, questions about blood components, blood group and safe blood transfusion.

  5 hours or 1 month

Study Arms (2)

Intervention

EXPERIMENTAL

Five modules of training on hemovigilance were given in 5 hours. A pre-test was applied at the beginning of the training. The final test was done at the end of the training. One month later, the same test was applied again to measure the permanence of the training.

Other: Training

Control

NO INTERVENTION

No training was provided. Only the pretest was administered one week after the posttest.

Interventions

Training OTHER

Hemovigilance module training

Intervention

Eligibility Criteria

• Age: 18 Years - 64 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• She/He voluntarily agrees to participate in the research, Working as a nurse in the clinic and intensive care unit where blood transfusions are the most, Working for at least 6 months,

You may not qualify if:

• Nurses working in the emergency and operating rooms, in clinics where blood transfusion is not performed the most, Being a new nurse, On maternity leave and maternity leave, Having an external assignment, Nurses working in the polyclinic,

Sponsors & Collaborators

• Ankara Yildirim Beyazıt University: lead

Study Sites (1)

Ankara Yıldırım Beyazıt University

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hypersensitivity

Condition Hierarchy (Ancestors)

Immune System Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: None (Open Label)
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Randomized, parallel-group, placebo-controlled study

Study Record Dates

• First Submitted: November 15, 2022
• First Posted: November 23, 2022
• Study Start: April 25, 2022
• Primary Completion: May 26, 2022
• Study Completion: July 8, 2022
• Last Updated: November 23, 2022

Record last verified: 2022-11

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)